Polynucleotides and their applications in diagnostics
CA 2358697 A1 · Owner: Smithkline Beecham Biologicals S.A. · Inventors: Vinals-Bassols, Carlota
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
CASB611, CASB500, CASB501, CASB502, CASB505 or CASB507 polypeptides and , polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB611 CASB500, CASB501, CASB502, CASB505, or CASB507 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colon cancers autoimmune diseases, and , related conditions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.